Medicine
Evomela 50 mg/10 mL powder for injection
Evomela 50 mg/10 mL powder for injection is a prescription medicine containing Melphalan for intravenous use, marketed by Acrotech Biopharma, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store Evomela at room temperature 25°C (77°F). Temperature excursions are…
Key facts
- Active ingredient (INN)
- Melphalan
- Brand
- Evomela
- Strength
- 50 mg/10 mL
- Dosage form
- Powder for injection
- Route
- Intravenous
- Packs
- 1 vial
- Marketing authorisation holder
- Acrotech Biopharma
- Manufacturer
- Acrotech Biopharma
- Origin register
- US FDA, United States
- Storage
- Store Evomela at room temperature 25°C (77°F). Temperature excursions are permitted between 15- 30°C (59-86°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- L01AA03 Melphalan
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 31 March 2016
- Identifiers
- RxCUI 311487, 1745090DailyMed set ID 69f55869-dc11-408e-8fc7-47634269a52cNDC 72893-001Application NDA207155
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 1 vial in 1 carton / 20 mL in 1 vial | 72893-001-01 | Acrotech Biopharma | 31 March 2016 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Melphalan
Clinical summary
Melphalan is an alkylating drug indicated as a high-dose conditioning treatment prior to hematopoietic progenitor (stem) cell transplantation in patients with multiple myeloma. It is available as injection and powder for injection for intravenous use. MedsAcross supplies Melphalan for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about MelphalanFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- EVOMELA prescribing information (Acrotech Biopharma) · U.S. National Library of Medicine, DailyMed
- Phelinun: European public assessment report (EPAR) · European Medicines Agency
Need Evomela 50 mg/10 mL powder for injection for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.